Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2109]

Thousands of high-risk cancer gene variants identified

Thousands of high-risk cancer gene variants identified

Approved drug may be repurposed to treat tumours resulting from NF2-Related schwannomatosis

Approved drug may be repurposed to treat tumours resulting from NF2-Related schwannomatosis

Rapid test of cerebrospinal fluid decreases time to diagnosis for brain tumours

Rapid test of cerebrospinal fluid decreases time to diagnosis for brain tumours

Anlotinibplus STUPP: A new hope for glioblastoma patients

Anlotinibplus STUPP: A new hope for glioblastoma patients

Children’s brain tumuors could be diagnosed with 10 min scan, based on metabolic signature

Children’s brain tumuors could be diagnosed with 10 min scan, based on metabolic signature

Study identifies potential pathway to reducing breast cancer brain metastases

Study identifies potential pathway to reducing breast cancer brain metastases

New glioblastoma treatment reaches human brain tumour and helps immune cells recognise cancer cells

New glioblastoma treatment reaches human brain tumour and helps immune cells recognise cancer cells

ASCO 2024: Drug targeting protein involved in control of immune response produces encouraging results in glioblastoma

ASCO 2024: Drug targeting protein involved in control of immune response produces encouraging results in...

New research platform assesses brain cancer mutations during surgery

New research platform assesses brain cancer mutations during surgery

The use of new technologies expands understanding of brain tumours in children

The use of new technologies expands understanding of brain tumours in children

More from ecancer